Cambium Medical Technologies, founded by four blood industry luminaries out of Emory University, Atlanta, Georgia (USA)--is focused on the development and commercialization of regenerative therapies derived from novel processed human platelets. Cambium is developing Elate Ocular a standardized, commercialized platelet derived biologic eye drop fordry eye syndrome (keratoconjunctivis sicca) as its first FDA approved therapy. Elate Ocular is an investigational drug and is not yet approved for sale in or outside the United States.

Health Care

Health Diagnostics

Therapeutics

Cambium Medical Technologies

Cambium Medical Technologies' headquarters in Atlanta, GA, United States

Terence A. Walts

Clayton W. Coley

Michael Broughton

Dennis E. Hannigan

John D. Roback

Edmund K. Waller

David Hiller

Cheryl L. Rowe-Rendleman

Steven Wilson

Zuguo Liu

Stephen C. Pflugfelder

Victor Perez

Paul Karpecki

Nelson Chao

Doyle Stulting

Description

People

Jobs